PTC Therapeutics, Inc. (PTCT)
68.17
+0.07
(+0.10%)
USD |
NASDAQ |
Feb 27, 16:00
68.17
0.00 (0.00%)
After-Hours: 19:01
PTC Therapeutics Research and Development Expense (Quarterly) : 133.13M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 192.41M |
| Sarepta Therapeutics, Inc. | 319.50M |
| Ardelyx, Inc. | 21.94M |
| Spyre Therapeutics, Inc. | 44.64M |
| Ovid Therapeutics, Inc. | 5.853M |